TRaaS On Product
6696
GMO AD Partners
4784
Bplats
4381
General Oyster
3224
CyberStep
3810
JP Stock MarketDetailed Quotes
4579 RaQualia Pharma
- 367
- +1+0.27%
20min DelayTrading Dec 25 14:54 JST
8.01BMarket Cap-24.50P/E (Static)
375High367Low124.90KVolume368Open366Pre Close46.25MTurnover72052wk High0.75%Turnover Ratio21.84MShares36252wk Low-31.13EPS TTM6.10BFloat Cap3320Historical HighLossP/E (Static)16.61MShs Float227Historical Low-14.98EPS LYR2.19%Amplitude--Dividend TTM1.41P/B100Lot Size--Div YieldTTM
RaQualia Pharma Key Stats
EPS
According to the latest financial report of RaQualia Pharma, the latest earnings per share (TTM) for the company is -11.36. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: JPY
Quarterly
Loading...
FCF
Interested in knowing about RaQualia Pharma's free cash flow? The latest report shows it as 357.62M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: JPY
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of RaQualia Pharma shows that the company's current ratio is 3.69, indicating healthy liquidity.
Currency: JPY
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of RaQualia Pharma, the quick ratio is 3.17, indicating that the company can meet its short-term debt obligations.
Currency: JPY
Quarterly
Loading...
ROE
Want to learn more about the financial health of RaQualia Pharma? The latest ROE figure is -4.22%, indicating that the company has stable profitability.
Currency: JPY
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of RaQualia Pharma, the total asset return on investment (ROA) is -2.36%.
Currency: JPY
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check RaQualia Pharma's latest financial report to see how their gross margin is doing - currently at 78.17%.
Currency: JPY
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of RaQualia Pharma, the net profit margin is -32.23%, which is a good sign for its profitability.
Currency: JPY
Quarterly
Loading...